ViiV Healthcare’s long-acting injectable Cabenuva has demonstrated superior virologic outcomes [...]

ViiV Healthcare’s two-drug HIV regimen Dovato was non-inferior to the [...]

ViiV Healthcare has secured FDA Priority Review for its application [...]

ViiV Healthcare, the global specialist HIV company majority owned by [...]

ViiV Healthcare will present new data from its long-acting and [...]

Cabotegravir and rilpivirine long-acting treatment proves highly effective and widely [...]